Multiple loci identified in a genome-wide association study of prostate cancer.

Multiple loci identified in a genome-wide association study of prostate cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Multiple loci identified in a genome-wide association study of prostate cancer. Abstract Text:

Gilles Thomas,Kevin B Jacobs,Meredith Yeager,Peter Kraft,Sholom Wacholder,Nick Orr,Kai Yu,Nilanjan Chatterjee,Robert Welch,Amy Hutchinson,Andrew Crenshaw,Geraldine Cancel-Tassin,Brian J Staats,Zhaoming Wang,Jesus Gonzalez-Bosquet,Jun Fang,Xiang Deng,Sonja I Berndt,Eugenia E Calle,Heather Spencer Feigelson,Michael J Thun,Carmen Rodriguez,Demetrius Albanes,Jarmo Virtamo,Stephanie Weinstein,Fredrick R Schumacher,Edward Giovannucci,Walter C Willett,Olivier Cussenot,Antoine Valeri,Gerald L Andriole,E David Crawford,Margaret Tucker,Daniela S Gerhard,Joseph F Fraumeni,Robert Hoover,Richard B Hayes,David J Hunter,Stephen J Chanock,

We followed our initial genome-wide association study (GWAS) of 527,869 SNPs on 1,172 individuals with prostate cancer and 1,157 controls of European origin-nested in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial prospective study-by testing 26,958 SNPs in four independent studies (total of 3,941 cases and 3,964 controls). In the combined joint analysis, we confirmed three previously reported loci (two independent SNPs at 8q24 and one in HNF1B (formerly known as TCF2 on 17q); P < 10(-10)). In addition, loci on chromosomes 7, 10 (two loci) and 11 were highly significant (between P < 7.31 x 10(-13) and P < 2.14 x 10(-6)). Loci on chromosome 10 include MSMB, which encodes beta-microseminoprotein, a primary constituent of semen and a proposed prostate cancer biomarker, and CTBP2, a gene with antiapoptotic activity; the locus on chromosome 7 is at JAZF1, a transcriptional repressor that is fused by chromosome translocation to SUZ12 in endometrial cancer. Of the nine loci that showed highly suggestive associations (P < 2.5 x 10(-5)), four best fit a recessive model and included candidate susceptibility genes: CPNE3, IL16 and CDH13. Our findings point to multiple loci with moderate effects associated with susceptibility to prostate cancer that, taken together, in the future may predict high risk in select individuals.

Multiple loci identified in a genome-wide association study of prostate cancer. Publishing Authors By Initials

G Thomas,KB Jacobs,M Yeager,P Kraft,S Wacholder,N Orr,K Yu,N Chatterjee,R Welch,A Hutchinson,A Crenshaw,G Cancel-Tassin,BJ Staats,Z Wang,J Gonzalez-Bosquet,J Fang,X Deng,SI Berndt,EE Calle,HS Feigelson,MJ Thun,C Rodriguez,D Albanes,J Virtamo,S Weinstein,FR Schumacher,E Giovannucci,WC Willett,O Cussenot,A Valeri,GL Andriole,ED Crawford,M Tucker,DS Gerhard,JF Fraumeni,R Hoover,RB Hayes,DJ Hunter,SJ Chanock,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Multiple loci identified in a genome-wide association study of prostate cancer. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Nature genetics

VOLUME: 40

Page Numbers: 310-5

Journal Abbreviation: Nat. Genet.

ISSN: 1546-1718

DAY: 10

MONTH: 02

YEAR: 2008

Multiple loci identified in a genome-wide association study of prostate cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9216904

Multiple loci identified in a genome-wide association study of prostate cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Multiple loci identified in a genome-wide association study of prostate cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Multiple loci identified in a genome-wide association study of prostate cancer.

AFFILIATION: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Nat Genet

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Multiple loci identified in a genome-wide association study of prostate cancer Related Publications

• A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.
• CYBB, an NADPH-oxidase gene: restricted diversity in humans and evidence for differential long-term purifying selection on transmembrane and cytosolic domains.
• CYP17 Genetic Variation and Risk of Breast and Prostate Cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
• Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies.
• Characterization of a candidate locus for malaria susceptibility in human populations: a (TA)n microsatellite in the promoter region of the CYBB gene, the gp91 phox subunit of the NADPH oxidase.
• Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer.
• Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers.
• Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.
• Genetic Variation in Sodium-Dependent Vitamin C Transporters SLC23A1 and SLC23A2 and Risk of Advanced Colorectal Adenoma.
• Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma.
• Multiple loci identified in a genome-wide association study of prostate cancer.
• Polymorphisms in folate metabolizing genes and risk for spontaneous preterm and small-for-gestational age birth.
• Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in china.